Chronic Kidney Disease: The State of the Art and Future Perspectives
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 32
Special Issue Editor
Interests: renal transplantation; live donor; immunosuppression; chronic rejection, HLA antibodies; graft survival; kidney exchange programs; desensitization; marginal donor; renal donor biopsies
Special Issue Information
Dear Colleagues,
Chronic kidney disease (CKD) is a highly prevalent condition and is associated with a marked increase in the risk of death and cardiovascular events. Chronic kidney disease is expected to become one of the top five causes of death by 2040. The increase in prevalence observed in recent decades is mainly due to the increase in diabetes mellitus and cardiovascular diseases and to the aging of the population. The number of people receiving kidney replacement therapy (KRT) will continue to increase in the coming years, especially in developing countries.
Recently, several new drugs have been introduced for the treatment of specific kidney diseases, for slowing the progression of chronic kidney disease, or for reducing CV risk. Even our understanding of the mechanisms underlying many kidney diseases, particularly immunologic or genetic diseases, has improved greatly, allowing for new treatment perspectives. There is hope that in the next few years, we will be able to reduce the number of new-incident patients who develop ESRD.
We are pleased to invite you to be part of this Special Issue on chronic kidney disease, which is a global health issue affecting approximately 700 million people. This Special Issue aims to improve treatment outcomes, benefiting patients and the broader society. We are looking for research articles and reviews focusing on CKD prevention, screening, and early treatment to prevent or delay CKD progression, thus reducing premature cardiovascular mortality and improving patients’ quality of life. Please note that manuscripts without molecular data will not be accepted.
Dr. Alberto Rosati
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- glomerulonephritis
- chronic kidney disease
- prevention
- screening
- cardiovascular mortality
- patient outcomes
- CKD progression
